Press Release

All the Latest Press Releases

PatientView press releases

2022

Aug

GERMAN EDITION: DIE REPUTATION DER PHARMAUNTERNEHMEN 2021
PRESS RELEASE – PAITENTVIEW: DIE REPUTATION DER PHARMAUNTERNEHMEN 2021

Read this press release
ENGLISH EDITION: CORP REP GERMANY EMBARGO
PRESS RELEASE – PATIENTVIEW: CORP REP GERMANY EMBARGO

Read this press release

Jul

UK EDITION: CORP REP UK EMBARGO
PRESS RELEASE – PATIENTVIEW: CORP REP UK EMBARGO

Read this press release
ENGLISH EDITION: CORP REP FRANCE EMBARGO
PRESS RELEASE – PATIENTVIEW: CORP REP FRANCE EMBARGO

Read this press release
FRENCH EDITION: COMMUNIQUÉ DE PRESSE – LA RÉPUTATION DES ENTREPRISES
PRESS RELEASE – PAITENTVIEW: COMMUNIQUÉ DE PRESSE – LA RÉPUTATION DES ENTREPRISES

Read this press release

Jun

PHARMA AND ESG: THE PATIENT PERSPECTIVE

PRESS RELEASE – PATIENTVIEW – PHARMA AND ESG: THE PATIENT PERSPECTIVE

Read this press release
CANADA EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2021

PRESS RELEASE – PAITENTVIEW – CANADA EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2021

Read this press release
HIV/AIDS EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2021

HIV/AIDS EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2021

Read this press release

May

CANCER EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2021
PRESS RELEASE – PATIENTVIEW – CORP REP CANCER EDITION

Read this press release
USA EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2021
PRESS RELEASE – PatientView – USA EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2021

Read this press release
TACKLING THE CHALLENGES OF GETTING A TIMELY DIAGNOSIS FOR ALZHEIMER’S DISEASE
PRESS RELEASE – PATIENTVIEW – TACKLING THE CHALLENGES OF GETTING A TIMELY DIAGNOSIS FOR ALZHEIMER’S DISEASE

Read this press release

Apr

GLOBAL EDITION: THE PATIENT PERSPECTIVE
PRESS RELEASE – PATIENTVIEW CORP REP GLOBAL EDITION PRESS RELEASE EMBARGO

Read this press release

2021

Nov

PRESS RELEASE MENTAL HEALTH – The Corporate Reputation of Pharma in 2020 during the Covid
PRESS RELEASE MENTAL HEALTH – The Corporate Reputation of Pharma in 2020 during the Covid.pdf

Read this press release

Oct

The Corporate Reputation of Pharma in 2020 during the Covid-19 Pandemic ― the Perspective of NEUROLOGY Patient Groups
PRESS RELEASE NEUROLOGY – The Corporate Reputation of Pharma in 2020 during the Covid

Read this press release
The Corporate Reputation of Pharma in 2020 during the Covid-19 Pandemic ― the Perspective of Autoimmune Patient Groups
PRESS RELEASE – AUTOIMMUNE – The Corporate Reputation of Pharma in 2020 during the Covid

Read this press release

Sep

The Corporate Reputation of Pharma in 2020 during the Covid-19 Pandemic ― the Perspective of Respiratory Patient Groups
PRESS RELEASE – RESPIRATORY EDITION PATIENTVIEW Corporate Reputation of Pharma in 2020 during the Covid

Read this press release
The Corporate Reputation of Pharma in 2020 during the Covid-19 Pandemic ― the Perspective of Rare-Disease Patient Groups
PRESS RELEASE – RARE DISEASES – The Corporate Reputation of Pharma in 2020 during the Covid

Read this press release
The Corporate Reputation of Pharma in 2020 during the Covid-19 Pandemic ― the Perspective of Italian Patient Groups
PATIENTVIEW PRESS RELEASE – ITALY – The Corporate Reputation of Pharma in 2020 during the Covid

Read this press release
The Corporate Reputation of Pharma in 2020 during the Covid-19 Pandemic ― the Perspective of Spanish Patient Groups
PATIENTVIEW PRESS RELEASE – SPAIN EDITION – The Corporate Reputation of Pharma in 2020 during the Covid

Read this press release

Aug

PatientView’s guide for pharma: BEING PATIENT CENTRIC AFTER A PANDEMIC
PATIENTVIEW PRESS RELEASE – PatientView’s guide for pharma: BEING PATIENT CENTRIC AFTER A PANDEMIC

Read this press release